Amino acid management in cancer.
Amino acids have a dual role in cellular metabolism, as they are both the building blocks for protein synthesis and intermediate metabolites which fuel other biosynthetic reactions. Recent work has demonstrated that deregulation of both arms of amino acid management are common alterations seen in cancer. Among the most highly consumed nutrients by cancer cells are the amino acids glutamine and serine, and the biosynthetic pathways that metabolize them are required in various cancer subtypes and the object of current efforts to target cancer metabolism. Also altered in cancer are components of the machinery which sense amino acid sufficiency, nucleated by the mechanistic target of rapamycin (mTOR), a key regulator of cell growth via modulation of key processes including protein synthesis and autophagy. The precise ways in which altered amino acid management supports cellular transformation remain mostly elusive, and a fuller mechanistic understanding of these processes will be important for efforts to exploit such alterations for cancer therapy.
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology, Department of Biology, Nine Cambridge Center, Cambridge, MA 02142, USA.
Zhi-Yang
ZY
Tsun
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA. Electronic address: Richard.Possemato@nyumc.org.
Richard
R
Possemato
D002952:Citric Acid Cycle / Q000502:physiology*; D005973:Glutamine / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000473:pathology*; D014176:Protein Biosynthesis / Q000502:physiology*; D012694:Serine / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*
D005973:Glutamine; D012694:Serine; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases
Amino acids; Cancer; Glutamine; Metabolism; Serine; mTOR